Dr. Matthew D Hellmann MD
Hematologist-Oncologist | Hematology & Oncology
300 E 66TH ST NEW YORK NY, 10065About
I am a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. I am dedicated to identifying better treatments for people with all stage ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
- Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
- ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.
- Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.
- 'Genotype/immunotype' correlations in resected NSCLC.
- Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.
- Reply to M. Nishino et al.
- Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
- Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
- Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Clinical Trials
- Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
- Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
- Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs
Treatments
- Lung Cancer, Immunotherapy, Clinical Trials
Dr. Matthew D Hellmann MD's Practice location
Dr. Matthew D Hellmann MD's reviews
Write ReviewPatient Experience with Dr. Hellmann
Recommended Articles
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
- How This Survivor Star Beat Hodgkin Lymphoma—Twice
Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...
- What are the Stages of Multiple Myeloma?
This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Superheroes Unite For Elementary Student Fighting Lymphoma
Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...
- AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
Nearby Providers
- Dr. Elan Diamond M.D.525 E 68th St New York NY 10065
- Dr. Ana Maria luisa Molina MD1275 York Ave New York NY 10065
- Dr. Yelena Y Janjigian MD1275 York Ave New York NY 10065
- Dr. Rekha Parameswaran M.D.1275 York Ave New York NY 10065
- Dr. Tessa Cigler MD425 E 61st St New York NY 10065
- Dr. Tomer Mark MD, MSC525 E 68th St New York NY 10065